Cargando…

Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature

Severe coronavirus disease (COVID-19) is currently managed with systemic glucocorticoids. Opportunistic fungal infections are of concern in such patients. While COVID-19 associated pulmonary aspergillosis is increasingly recognized, mucormycosis is rare. We describe a case of probable pulmonary muco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garg, Deepak, Muthu, Valliappan, Sehgal, Inderpaul Singh, Ramachandran, Raja, Kaur, Harsimran, Bhalla, Ashish, Puri, Goverdhan D., Chakrabarti, Arunaloke, Agarwal, Ritesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862973/ https://www.ncbi.nlm.nih.gov/pubmed/33544266 http://dx.doi.org/10.1007/s11046-021-00528-2

Ejemplares similares

COVID-19, mucormycosis, and the cow: Damned lies!
por: Muthu, Valliappan, et al.
Publicado: (2023)

COVID-19-Associated Pulmonary Mucormycosis: An Underdiagnosed Entity with High Mortality
por: Muthu, Valliappan, et al.
Publicado: (2022)

Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World
por: Muthu, Valliappan, et al.
Publicado: (2021)

CT Findings of COVID-19–associated Pulmonary Mucormycosis: A Case Series and Literature Review
por: Garg, Mandeep, et al.
Publicado: (2021)

Clinical and Mycologic Characteristics of Emerging Mucormycosis Agent Rhizopus homothallicus
por: Rudramurthy, Shivaprakash M., et al.
Publicado: (2023)

Serum glucose-regulated protein 78 (GRP78) levels in COVID-19-associated mucormycosis: results of a case–control study
por: Muthu, Valliappan, et al.
Publicado: (2022)

Allergic bronchopulmonary aspergillosis
por: Agarwal, Ritesh, et al.
Publicado: (2020)

The minimal important difference of six-minute walk test in subjects with chronic pulmonary aspergillosis treated with six-months of oral itraconazole
por: Sehgal, Inderpaul S., et al.
Publicado: (2023)

Fungal bronchitis or allergic bronchopulmonary aspergillosis …that is the question
por: Sehgal, Inderpaul Singh, et al.
Publicado: (2021)

P395 Clinical utility of semi-nested conventional PCR for diagnosis of mucormycosis in fresh clinical samples
por: Choudhary, Hansraj, et al.
Publicado: (2022)

Evaluation of Simpler Criteria for Diagnosing Allergic Bronchopulmonary Aspergillosis Complicating Asthma
por: Agarwal, Ritesh, et al.
Publicado: (2022)

Clinical significance and epidemiological evolution of epitrochlear lymphadenopathy in pre- and post-highly active antiretroviral therapy era: A systematic review of the literature
por: Muthu, Valliappan, et al.
Publicado: (2018)

P408 Evaluation of fungal serum biomarkers in the diagnosis and for monitoring patients with post tuberculosis chronic pulmonary aspergillosis
por: Singh, Shreya, et al.
Publicado: (2022)

Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India
por: Patel, Atul, et al.
Publicado: (2021)

Prevalence of Vitamin D Deficiency in Treatment-Naïve Subjects with Chronic Pulmonary Aspergillosis
por: Sehgal, Inderpaul Singh, et al.
Publicado: (2020)

Role of serum procalcitonin in the diagnosis and monitoring of treatment response in treatment-naïve subjects with chronic pulmonary aspergillosis
por: Sehgal, Inderpaul Singh, et al.
Publicado: (2023)

Removal of an inadvertently deployed self-expanding metallic Y stent
por: Muthu, Valliappan, et al.
Publicado: (2017)

High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial)
por: Dhooria, Sahajal, et al.
Publicado: (2022)

Allergic bronchopulmonary aspergillosis presenting as nephrotic syndrome due to secondary amyloidosis: Case report and systematic review of the literature
por: Muthu, Valliappan, et al.
Publicado: (2018)

Aspergillus Sensitization and Allergic Bronchopulmonary Aspergillosis in Asthmatic Children: A Systematic Review and Meta-Analysis
por: Agarwal, Ritesh, et al.
Publicado: (2023)

Active pulmonary tuberculosis and coronavirus disease 2019: A systematic review and meta-analysis
por: Aggarwal, Ashutosh Nath, et al.
Publicado: (2021)

Is high-dose glucocorticoid beneficial in COVID-19?
por: Muthu, Valliappan, et al.
Publicado: (2021)

Malaria-associated secondary haemophagocytic lymphohistiocytosis: Report of two cases & a review of literature
por: Muthu, Valliappan, et al.
Publicado: (2017)

Risk factors for clinically significant diffuse parenchymal lung abnormalities persisting after severe COVID-19 pneumonia
por: Dhooria, Sahajal, et al.
Publicado: (2023)

Where there is a balloon, there is a way!
por: Muthu, Valliappan, et al.
Publicado: (2020)

The Reversed Halo Sign and the Bronchus Sign: The Eyes See Only What the Mind Knows
por: Muthu, Valliappan, et al.
Publicado: (2019)

Autoimmune pulmonary alveolar proteinosis and sarcoidosis in the same patient: Case report and systematic review
por: Shrestha, Deepa, et al.
Publicado: (2022)

Barrier Protection during Airway Intubation
por: Sehgal, Inderpaul S, et al.
Publicado: (2020)

Safety of an immunomodulator Mycobacterium w in COVID-19
por: Sehgal, Inderpaul Singh, et al.
Publicado: (2020)

Transforming a General Hospital to an Infectious Disease Hospital for COVID-19 Over 2 Weeks
por: Pandey, Navin, et al.
Publicado: (2020)

Etiology and Outcomes of ARDS in the Elderly Population in an Intensive Care Unit in North India
por: Sehgal, Inderpaul S, et al.
Publicado: (2021)

Corticosteroids for Non-severe COVID-19: Primum Non Nocere
por: Muthu, Valliappan, et al.
Publicado: (2022)

Barrier enclosure device to sample difficult to access lesions by endobronchial ultrasound during the pandemic
por: Rao, Harshith, et al.
Publicado: (2022)

Cystic lung lesion following transbronchial lung cryobiopsy: Case report and systematic review
por: Malegaonkar, Srikant Kashinath, et al.
Publicado: (2023)

A real-world evaluation of severe asthmatics referred for bronchial thermoplasty
por: Prasad, Kuruswamy Thurai, et al.
Publicado: (2022)

Comparative accuracy of pleural fluid unstimulated interferon-gamma and adenosine deaminase for diagnosing pleural tuberculosis: A systematic review and meta-analysis
por: Aggarwal, Ashutosh Nath, et al.
Publicado: (2021)

Barrier enclosure device: One size does not fit all
por: Sehgal, Inderpaul Singh, et al.
Publicado: (2021)

Barrier enclosure device during patient preparation for flexible bronchoscopy
por: Sehgal, Inderpaul Singh, et al.
Publicado: (2020)

Risk stratification of acute respiratory distress syndrome using a PaO2: Fio2 threshold of 150 mmHg: A retrospective analysis from an Indian intensive care unit
por: Sehgal, Inderpaul Singh, et al.
Publicado: (2020)

Impact of COVID-19 pandemic on tuberculosis notifications in India
por: Aggarwal, Ashutosh Nath, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i3692r09ulknd0pmt1k8qsta76